Egon Zehnder recently invited CTOs from top U.S. biopharma companies to discuss their experiences and best practices in today’s rapidly changing environment
Hiring in the start-up world is no longer a linear path, and leaders will need to stay ahead of their future needs when it comes to talent. It’s about timing, and here is how they can get their strategy right.
Egon Zehnder rounded off 2020 with a final gathering of biotech CEOs and board members, who shared their reflections on a turbulent year.
Senior Biotech R&D execs brainstorm on saving clinical trials, modifying procedures, and getting people back to work.
As Contract Development and Manufacturing Organizations (CDMOs) in the BioPharma space have boomed and broadened their capabilities in recent years, they have entered a more complex era that presents a host of new challenges.
As food industry leaders continue to understand the power and potential of personalized nutrition, they are challenged with bringing together scientific expertise and marketing prowess.
You are switching to an alternate language version of the Egon Zehnder website. The page you are currently on does not have a translated version. If you continue, you will be taken to the alternate language home page.
Continue to the website